Last Posted: Feb 14, 2020
- An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice-A Review
M Rainone et al, JAMA Oncology, February 13, 2020 - Focus group testing of a mobile app for pharmacogenetic-guided dosing.
Dodson Crystal Heath et al. Journal of the American Association of Nurse Practitioners 2020 Feb - Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine.
Mehta Darshan et al. Drug discovery today 2020 Feb - Circulating tumor DNA analysis in the era of precision oncology.
Said Rabih et al. Oncotarget 2020 Jan 11(2) 188-211 - Pharmacogenomics: An evolving clinical tool for precision medicine.
Hockings Jennifer K et al. Cleveland Clinic journal of medicine 2020 Feb 87(2) 91-99 - Precise hepatectomy in the intelligent digital era.
Chen Hao et al. International journal of biological sciences 2020 16(3) 365-373 - Precision medicine in Ewing sarcoma: a translational point of view.
Gargallo P et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2020 Feb - Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
Lin Eugene et al. International journal of molecular sciences 2020 Feb 21(3) - Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.
Jiang Ruirui et al. Scientific reports 2020 Feb 10(1) 2070 - A 2020 Reality Check on the Public Health Impact of Cancer Genomics and Precision Medicine
Khoury MJ et al, CDC BLog, February 10, 2020
.jpeg)
No hay comentarios:
Publicar un comentario